(lp0
S"Cytokinetics, Inc. Reports Fourth Quarter 2016 Financial Results GlobeNewswire  - Feb 16, 2017 16, 2017  -- Cytokinetics, Inc.  reported total revenues for the fourth quarter of 2016 were $33.1 million, compared to $9.8 million, during the same period in 2015.Cytokinetics'  CEO Robert Blum on Q4 2016 Results - Earnings Call Transcript - Seeking AlphaPlenty of Catalysts Ahead for Cytokinetics  - Economic Calendar"
p1
aS"Why Cytokinetics, Inc. Got Hammered Today Motley Fool - Sep 1, 2016 Not mentioning an SPA doesn't mean that Amgen and Cytokinetics don't have one, although it would be a little weird to leave it out of the press release.Here's Why You Should Buy Cytokinetics, Inc.  As Amgen, Inc. (AMGN ... - TCCCytokinetics , Amgen  to Advance Omecamtiv Mecarbil to Phase 3 - StreetInsider.com"
p2
aS'11.60 MarketWatch - Dec 21, 2009 Cytokinetics Inc. Watchlist CreateCYTKAlert. After Hours. Last Updated: Apr 13, 2017 4:32 p.m.. $ 11.60. 0.00 0.00%.'
p3
aS'Cytokinetics to Announce First Quarter Results on April 27, 2017 GlobeNewswire  - Apr 13, 2017 SOUTH SAN FRANCISCO, Calif., April 13, 2017  -- Cytokinetics, Inc.  today announced that it is scheduled to report first quarter results on Thursday, April 27, 2017 at 4:00 PM Eastern Time.'
p4
aS'Gigamon, CBL &amp; Associates Properties and Cytokinetics Set to Join S&amp;P SmallCap 600 PR Newswire  - 12 hours ago Cytokinetics Inc.  will replace Cardinal Financial Corp.  effective prior to the open on Monday, April 24.'
p5
aS"Cytokinetics and Astellas Announce Option Right for Tirasemtiv and Expansion ... GlobeNewswire  - Jul 27, 2016 SOUTH SAN FRANCISCO, Calif. and TOKYO, July 27, 2016  -- Cytokinetics, Inc.   and Astellas Pharma Inc.   today announced that Cytokinetics and Astellas have expanded their&nbsp;...With latest swing, Peninsula biotech tries to double up Lou Gehrig's disease - San Francisco Business Times Cytokinetics Gets $95M in First ALS Deal, Needs Results For More - Xconomy"
p6
aS'Cytokinetics to Present at the 16th Annual Needham Healthcare Conference GlobeNewswire  - Mar 22, 2017 SOUTH SAN FRANCISCO, Calif., March 29, 2017  -- Cytokinetics, Inc.  today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at the 16th Annual Needham&nbsp;...'
p7
aS'Cytokinetics, Inc.  Reaches $11.70 After 6.00% Up Move; Guess?, Inc ... Key Gazette - Apr 12, 2017 Cytokinetics, Inc.  has risen 11.76% since September 6, 2016 and is uptrending. It has outperformed by 4.11% the S&amp;P500.'
p8
aS"JMP Securities Bullish on Cytokinetics, Inc.  Following 2Q Update; Sees ... Smarter Analyst - Aug 1, 2016 In light of Cytokinetics, Inc.'s  second-quarter update, JMP Securities analyst Jason Butler remains bullish for the biotech company's pipeline drug-paved road ahead."
p9
aS'Cytokinetics Announces Start of GALACTIC-HF, a Phase 3 Clinical Trial of ... GlobeNewswire  - Dec 1, 2016 SOUTH SAN FRANCISCO, Calif., Dec. 01, 2016  -- Cytokinetics, Inc.  today announced the activation of the first clinical site and the start of GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes&nbsp;...Cytokinetics earns $26.7M milestone from Amgen on start of large-scale CV ... - Seeking Alpha'
p10
a.